• Dry Cracked Skin
  • Impetigo
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Surgery
  • Melasma
  • NP and PA
  • Anti-Aging
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Inflamed Skin

NOVARTIS PULLS AD

Article

Novartis has pulled its TV ad for Lamisil from the air after receiving a letter from the FDA objecting to the sequence in which Novartis presents the qualifying and efficacy information for its anti-fungal.

Related Videos
Related Content
Dual-Wavelength Laser Technology Demonstrates Promise in Atrophic Acne Scar Management

Dual-Wavelength Laser Technology Demonstrates Promise in Atrophic Acne Scar Management

Article
The Cutaneous Connection: Pearls for Atopic Dermatitis in College-Aged Patients

The Cutaneous Connection: Pearls for Atopic Dermatitis in College-Aged Patients

Podcast
Discovering Dermatology Times: November 2023 Corticosteroid-Responsive Dermatoses Supplement

Discovering Dermatology Times: November 2023 Corticosteroid-Responsive Dermatoses Supplement

Article
The Cutaneous Connection: Understanding Age-Approved Therapies in the Atopic Dermatitis Armamentarium

The Cutaneous Connection: Understanding Age-Approved Therapies in the Atopic Dermatitis Armamentarium

Podcast
Greater Understanding Necessary in Treatment of Periorbital Facial Necrotizing Fasciitis, Review Argues

Greater Understanding Necessary in Treatment of Periorbital Facial Necrotizing Fasciitis, Review Argues

Article
First Real-World Report of Near Complete Response With Cemiplimab in Penile Squamous Cell Carcinoma, Study Confirms

First Real-World Report of Near Complete Response With Cemiplimab in Penile Squamous Cell Carcinoma, Study Confirms

Article
© 2023 MJH Life Sciences

All rights reserved.